Demetrix

About:

Demetrix is a biotechnology company that researches and produces bioactive ingredients.

Website: https://www.demetrixbio.com

Twitter/X: demetrixbio

Top Investors: Horizons Ventures, Berkeley Catalyst Fund (BCF), Tuatara Capital

Description:

Demetrix uses fermentation technology to produce rare cannabinoids for the health and wellness industries. The company identifies rare bioactive compounds and, through rigorous research, develops those with the greatest potential for human health and well-being. Their methods mimic nature’s chemistry, and we produce bioactive efficiently and affordably, maintaining a light environmental footprint. Demetrix is based in Berkeley, CA, with offices in Raleigh, NC.

Total Funding Amount:

$61M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Berkeley, California, United States

Founded Date:

2017-01-01

Contact Email:

contact(AT)demetrix.com

Founders:

Jay Keasling, William Haseltine

Number of Employees:

101-250

Last Funding Date:

2019-07-11

IPO Status:

Private

Industries:

© 2025 bioDAO.ai